ENST00000654191.1:n.517-1119C>T

Variant summary

Our verdict is . The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000654191.1(ENSG00000228566):​n.517-1119C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0633 in 152,208 control chromosomes in the GnomAD database, including 606 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.063 ( 606 hom., cov: 32)

Consequence

ENSG00000228566
ENST00000654191.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.269

Publications

1 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000654191.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.155 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000654191.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000228566
ENST00000654191.1
n.517-1119C>T
intron
N/A
ENSG00000228566
ENST00000660795.1
n.266-1119C>T
intron
N/A
ENSG00000228566
ENST00000764129.1
n.211-1119C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0632
AC:
9607
AN:
152090
Hom.:
603
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.158
Gnomad AMI
AF:
0.0329
Gnomad AMR
AF:
0.0588
Gnomad ASJ
AF:
0.0498
Gnomad EAS
AF:
0.0256
Gnomad SAS
AF:
0.0319
Gnomad FIN
AF:
0.00528
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0214
Gnomad OTH
AF:
0.0616
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0633
AC:
9639
AN:
152208
Hom.:
606
Cov.:
32
AF XY:
0.0613
AC XY:
4560
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.159
AC:
6586
AN:
41512
American (AMR)
AF:
0.0591
AC:
903
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0498
AC:
173
AN:
3472
East Asian (EAS)
AF:
0.0259
AC:
134
AN:
5180
South Asian (SAS)
AF:
0.0311
AC:
150
AN:
4826
European-Finnish (FIN)
AF:
0.00528
AC:
56
AN:
10614
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0214
AC:
1455
AN:
67992
Other (OTH)
AF:
0.0614
AC:
130
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
433
867
1300
1734
2167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0334
Hom.:
119
Bravo
AF:
0.0733
Asia WGS
AF:
0.0420
AC:
145
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.8
DANN
Benign
0.59
PhyloP100
0.27

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.